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Summary
Set up:  One Tuberculosis Unit (TU) in Tiruvallur district, Tamil Nadu, India where Tuberculosis (TB) patients treated
under Directly Observed Treatment Short Course (DOTS) programme.
Objective:  To identify the effects of weight gain among TB patients at the end of treatment on different factors such
as socio-economic and demographic characteristics, smoking and drinking habits, treatment under supervision, the type
of DOTS centres and problems in taking drugs.
Methods:  TB patients registered between May 1999 and December 2004 formed the study population. Multiple
regression method was used for the analysis.
Results:   Among 1557 smear-positive TB patients registered under DOTS programme, the changes in weight ranged
from a loss of 4 kgs to a gain of 20 kgs at the end of TB treatment; the average change in weight was 3.22 kgs.  The gain
in weight at the end of treatment was associated with age (<45 years), DOT at government centres, no problems in taking
drugs as reported by patients and cure rate.
Conclusion:    The findings showed that there is an association between gain in weight with DOT at government centres
and cure of patients.
Key words: Tuberculosis, Weight gain after treatment, Multiple regression.
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INTRODUCTION
Patients with Tuberculosis (TB) often suffer
from severe weight loss, a symptom that is
considered immuno-suppressive and a major
determinant of severity and disease outcome1.
Malnutrition is an important risk factor for TB,
because cell-mediated immunity (CMI) is the key
host defense against TB.  The association between
body weight, TB mortality and morbidity has been
studied extensively since 19862-4.  Directly Observed
Treatment Short-course (DOTS) is the
internationally recommended strategy for TB
control, adopted as the Revised National TB Control
Programme (RNTCP) in India since 1997.  The
country was covered under the programme by
March 2006 and has almost achieved the global target
of 85% cure and 70% case detection.  There are
about 8.9 million patients with TB in India, of whom
half are infectious (sputum smear-positive
pulmonary TB)5. Currently, nation wide coverage
results in a success rate of 86% and a death rate of
4%6.
The weight of the patient taken at different
time points during treatment is an important
component to assess the progress of   patients. The
relationship between change in weight among
patients during anti-TB treatment and other factors
such as socio-economic demographic
characteristics, smoking and drinking habits,
whether the patient took treatment under
supervision, the type of DOT centres and problems
in taking drugs has not been well documented.  The
objective of the study was to identify  the  association
of weight gain during treatment to these factors and
relative importance of these in RNTCP.
METHODS
The study was conducted at a rural TB unit
(TU) in Tiruvallur district, South India.  The study
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area included 209 villages and nine urban clusters
consisting of a population of 5,80, 000 scattered
across approximately 200 km2.  The DOTS
strategy has been implemented in this area since
May 19997. Seventeen governmental health
facilities (HFs) participate in the programme and,
of these, seven offer diagnostic facilities for
sputum examination.  All the patients diagnosed
with TB at one of these HFs are given DOT in
accordance with RNTCP policies7.   This study
was approved by the Scientific Advisory
Committee and the Institutional Ethics Committee
as per the Indian Council of Medical Research
(ICMR) guidelines.
Between May 1999 and December 2004,
5366 TB patients were registered for treatment
under DOTS in this area. Data on socio- economic
and demographic characteristics was collected
within a week of starting the treatment. Trained
field staff interviewed the patients at their
residence and collected information on smoking
and drinking habits (only from men), whether the
patient took treatment under supervision, the type
of DOTS centres and any problems in taking
drugs using a pre-tested semi-structured
questionnaire.  Data regarding treatment outcome
was collected at the end of the treatment from
the TB register maintained at the TU. Standard
international definitions were followed to classify
TB patients according to outcome8. Weight
recorded at the initial stage of treatment and at
the end of anti-TB treatment was collected from
the treatment cards of the patients.
Data were scrutinized and entered twice
in order to ensure accuracy, corrected for
discrepancy and missing information.  The
analysis was confined to smear-positive cases and
hence extra-pulmonary cases and Category III
patients were removed from final analysis.
Multiple regression (SPSS version 13.0) was
performed to identify the association of weight
gain on different factors.  The adjusted hazard
ratio and 95% confidence intervals (CI) were
estimated for the factors.  The level of statistical
significance was defined as p<0.05.
RESULTS
Among the 5366 TB patients, 1557 smear-
positive patients whose weight was available at the
initiation of treatment, and at the end of treatment
were considered for the analysis.  Of the 1557 TB
patients registered under DOTS programme, 1175
(75%) were males, 690 (44%) were aged 45 years
or more, 623 (40%) were illiterate and 478 (31%)
were unemployed.  Major life style indicators for
the patients included the following:  638 (41%)
smokers and 474 (30%) alcoholics.  Of the 1557
patients, 1285 (83%) were treated under Category
I, and 272 (17%) were treated under Category II
(Table 1).  For these patients, the treatment outcomes
were as follows: 1394 (89.5%) were cured, four
(0.3%) completed treatment, 52 (3.3%) defaulted,
nine (0.6%) expired, 97 (6.2%) failed treatment and
one (0.1%) was transferred out.
The mean weight of patients at the initial
stage of treatment was 42 kgs.  At the end of
treatment, the change in weight for 1557 patients
by category- wise is set out in Table 2.  Overall, the
change in weight ranged from a loss of 4 kgs to a
gain of 20 kgs with an average change in weight of
3.22 kgs.  Weight remained constant from initial
stage to the end of treatment for 98 (6.3%) patients.
Sixty-eight (4.4%) patients lost weight (mean = -
1.79, Standard Deviation (SD) = 1.43, range (-9,-
1) where as 1391(89.3%) attained weight (mean =
3.67, SD = 2.45, range (1, 20).  Among the 1391
patients, 228 (16.4%) patients gained weight less
than 2 kgs, 762 (54.8%) gained 2-4 kgs, 401 (28.8%)
gained more than 4 kgs.
Among the Category I patients, the change
in weight ranged from -4 to 20 kgs with an average
of 3.34 kgs whereas among Category II, it ranged
from -3 to 13 kgs with an average of 2.56 kgs.
Weight remained constant from initial stage to end
of treatment for 72 (5.6%) Category I patients
compared to 26 (9.6%) Category II patients. The
corresponding figures for patients who lost weight
were 42 (3.3%) and 26 (9.6%); and for those gained
weight were 1171(91.1%) and 220 (80.8%)
respectively. The difference in weight gain between
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Category 1 and Category II patients was statistically
significant (p<0.001).
The gain in weight at the end of treatment
was associated with age (<45 years) (p<0.05),
Government DOTS centres (p<0.05), no
problems in taking drugs (p<0.01) and cure rate
(p<0.05). (Table 3).
DISCUSSION
This study showed that weight gain during
the treatment was associated with age (<45 years),
DOT at government centres, no problems in taking
drug as reported by patients and cure of patients.
TB control programme prevents infection and stops
progression from infection to active disease, treats
all active cases and completely cures all of them.
The DOTS strategy has been found to be very
effective all over the world and our country has
almost achieved the global target.  In the study area,
the success rate of patients treated under DOTS
during the study period was about 80%.  Patients
put on treatment gaining body weight show
improvement towards the end of treatment.  Our
study has supported that the cure is significantly
associated with patient’s gain in body weight.
Another factor associated with gain in weight was
age of the patients; younger patients are more likely
to gain body weight during treatment compared to
older patients.  Patients who took treatment at
Government centres and those who reported that
they had no problems in taking drugs were more
likely to have gained body weight.
There are many studies that have shown
the effect of body weight on the treatment outcome.
An earlier report from our centre7 showed that 39
(6%) of 676 TB patients died during the treatment
period, and that higher death rates were
independently associated with base line body weight
<35 kgs and a history of previous treatment for TB.
The study recommended that nutritional interventions
should be considered among underweight patients
to reduce mortality.  Another study from our centre
found that the higher death rates were independently
associated with patient’s age (≥45 years), previous
history of treatment, alcoholism and initial body
Table 1: Characteristics of TB patients registered
under DOTS in a rural district, south India 
Factors n = 1557 Total (%)   
Sex  
Female 382 (25) 
Male 1175 (75) 
Age (Years)  
<45 867 (56) 
≥45 690 (44) 
Education  
Illiterate 623 (40) 
Literate 828 (53) 
Non-availability 106 (7) 
Occupation  
Unemployed 478 (31) 
Employed 974 (62) 
Non-availability 105 (7) 
Smoking  
No 813 (52) 
Yes 638 (41) 
Non-availability 106 (7) 
Alcoholism  
No 978 (63) 
Yes 474 (30) 
Non-availability 105 (7) 
DOT centre  
Government  931 (60) 
Non-Government 529 (34) 
Non-availability  97 (6) 
Supervision under IP  
No                      319 (20) 
Yes                    1130 (73) 
Non-availability                        108 (7) 
Problem in taking drugs  
No 476 (30) 
Yes 588 (38) 
Non-availability 493 (32) 
Category  
I 1285 (83) 
II 272 (17) 
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weight (<35 kgs)9.  In another study, the treatment
success rate was increased as the body weight
increased, and the increase in trend was statistically
significant (Trend Chi square 22.0; p<0.001)
(unpublished).   All these findings showed that
patient’s body weight is associated with treatment
outcome. Our study has substantiated this finding
of the association between weight gains of patients
with cure of the patients. The proportion of Category
I patients who gained weight was significantly higher
compared to Category II patients. This finding
emphasizes that patients under treatment have to
Table 2: Category-wise distribution of change in weight at end of treatment period
Difference in weight (kgs) 
Category No. of 
patients No change 
No. (%) 
Loss 
No. (%) 
Gain 
No. (%) 
Average (Range) 
(kgs) 
I 1285 72 (5.6) 42 (3.3) 1171 (91.1) 3.34 (-4, 20) 
II 272 26 (9.6) 26 (9.6) 220 (80.8) 2.56 (-3, 13) 
Total 1557 98 (6.3) 68 (4.4) 1391 (89.3) 3.22 (-4, 20) 
 
 
 
 
Table 3: Results of the multiple regression analysis of factors for gain in weight among 904 TB
patients at the end of treatment
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Non-standardised 
Co-efficient Factors 
 B S.E  
Standardized 
Regression 
Co-efficient 
95% C.I for B P 
Male  -0.035 0.232 -0.006 (-0.490, 0.420) 0.879 
Age (<45 years) 0.349 0.173 0.071 (0.010, 0.689) <0.05 
Cure of the patient  0.350 0.135 0.086 (0.084, 0.615) <0.05 
Employed 0.059 0.181 0.012 (-0.296, 0.413) 0.745 
Non-smokers -0.075 0.219 -0.015 (-0.505,0.355) 0.731 
Non-alcoholics -0.134 0.210 -0.026 (-0.547,0.279) 0.525 
DOT at Government. 
Centres 
0.346 0.164 0.071 (0.025, 0.668) <0.05 
Treatment under 
supervision 
0.294 0.214 0.046 (-0.125,0.714) 0.169 
No problems in 
taking drugs 
0.434 0.163 0.089 (0.115, 0.753) <0.01 
B – Regression co-efficient, S.E- Standard error, C.I – Confidence Interval 
The number of patients is less than 1557 due to non-availability of patients at the time of interview, within a week after 
treatment started.   
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complete the full course of DOT without
interruption.  Khan et al reported that among persons
who were underweight at diagnosis, weight gain of
5% or less among underweight tuberculosis patients
after two months of treatment was associated with
an increased risk of relapse10.
A study from Japan reported that the ageing
of the Japanese population partially accounts for the
increase in the number of patients with TB.  The
disease is often transmitted from these aged patients
to those who were uninfected.  After admission, in
patients showing negative conversion of bacilli, there
was a positive correlation between the increase in
PNI (Prognostic Nutritional Index) and the gain of
body weight (p<0.01, r=0.30) 11.  Weight loss is
associated with impaired physical function as well
as increased mortality in patients with TB. Our study
highlights the need to improve the body weight during
treatment for a successful treatment outcome. A
higher likelihood of weight gain was associated with
patients taking treatment in DOT at government
centres. Another important finding of this study was
the need to have DOTS patient friendly.
In conclusion, weight gain at the end of
treatment was associated with age (<45 years),
DOT at government centres, no problems in
taking drug as reported by patients and cure of
patients. TB patients should be educated on
optimizing nutritional intake as part of the
routine management of TB control programme.
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